姓名：潘啟安 性别：男 职称：主任医师、教授 招生院所：地坛医院 招生类型：科学与专业学位(博) 科学与专业学位(硕) 招生专业：内科学（传染病）(博) 内科学（传染病）(硕) 研究方向名称：感染性肝病的预防和治疗 电子信箱：cpan11355@yahoo.com


社会任职
1. 美国肝脏病学会（AASLD)，曾任网上教育委员会， 主委
2. 亚太病毒性肝炎扑灭联盟 (CEVHAP), 现任委员
3. 美国华人医生协会 (ACAP)， 曾任副主任委员
个人简历
1. 200207-200304:美国纽约市法拉盛医院医疗中心 任职医师
2. 200305-200406:美国纽约西奈山医学院附属艾姆赫斯特医院 任职医师
3. 200407-200912:美国纽约西奈山医学院附属艾姆赫斯特医院 助理教授
4. 201001-201208:美国纽约西奈山医学院附属艾姆赫斯特医院 任副教授
5. 201209-:美国纽约大学医学院附属郎格尼医疗中心 任正教授
6. 202001-:北京首都医科大学附属北京地坛医院 兼职正教授
重要学术论文
1. Pan CQ*, Gayam V, Rabinovich C, Normatov M, Fidman B, Wang D, Garlapati P..Efficacy of Direct-Acting Antivirals for Chronic Hepatitis C in a Large Cohort of Older Adults in the United States. . Journal of the American Geriatrics Society. . 2020,68(2):379-87 .SCI
2. Younossi ZM*, Stepanova M, Younossi I, Pan,CQ, Janssen HL.A, Papatheodoridis G, Nader F..Long-term Effects of Treatment for Chronic HBV Infection on Patient-Reported Outcomes. Clin Gastroenterol Hepatol. 2019;17(8):1641-2 e1. Clin Gastroenterol Hepatol.. 2019,17(8):1641-2.SCI
3. Pan CQ, Zhang H* .Tenofovir Disoproxil Fumarate Is Safe to Prevent Mother-to-child transmission of Hepatitis B Virus.. Aliment Pharmacol Ther. . 2019,50(4):477-8..SCI
4. Pan CQ*.Put on your thinking cap - Tenofovir Disoproxil Fumarate for prevention of hepatitis B vertical transmission. Aliment Pharmacol Ther. 2019;49(6):824-5.. Aliment Pharmacol Ther. . 2019,49(6):824-5..SCI
5. Wang M, Bian Q, Zhu Y, Pang Q, Chang L, Li R, Tiongson BC, Zhang H, Pan CQ.*.Real-world study of tenofovir disoproxil fumarate to prevent hepatitis B transmission in mothers with high viral load. Aliment Pharmacol Ther. . 2018,49(2):211-7..SCI
6. Yi W#, Pan CQ#, Li MH, Wan G, Lv YW, Liu M, Hu YH, Zhang ZY,* Xie Y*.The characteristics and predictors of postpartum hepatitis flares in women with chronic hepatitis B. . Am J Gastroenterol . 2018,113(5):686-693.SCI
7. Tong MJ*, Pan CQ, Han SB, Lu DS, Raman S, Hu KQ, Lim JK, Hann HW, Min AD. .An expert consensus for the management of chronic hepatitis B in Asian Americans.. Aliment Pharmacol Ther . 2018,47(8):1181-200. .SCI
8. Agarwal K*, Brunetto M, Seto WK, Lim YS, Fung S, Marcellin P, Ahn SH, Izumi N, Chuang WL, Bae H, Sharma M, Janssen, HLA, Pan CQ, Çelen MK, Furusyo N, Shalimar D, Yoon KT, Trinh H, Flaherty JF, Gaggar A, Lau AH, Cathcart AL, Lin L, Bhardwaj N, Suri V, Mani SG, Gane EJ, Buti M, Chan HL.96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection. Journal of Hepatology. 2018,68(4):672-81.SCI
9. Park JS, Pan CQ*.Viral factors for HBV mother-to-child transmission. Hepatol Int.. 2017,11(6):476-480.SCI
10. Pan CQ*, Duan ZP, Dai EH, Zhang SQ, Han GR, Wang YM, Zhang HH, Zou HB, Zhu BS, Zhao WJ, Jiang HX. Tenofovir Therapy on Preventing Transmission of Hepatitis B in Mothers with High Viral Load.Tenofovir Therapy on Preventing Transmission of Hepatitis B in Mothers with High Viral Load. The New England Journal of Medicine. 2016,374 :2324-34..SCI
11. Ahn, J*; Nguyen, M H; Lim, J K; Lee, H M; Pan, C Q; Lok, A S. .Lessons from the 'real-world' entecavir therapy in chronic hepatitis B patients.. Aliment Pharmacol Ther. 2016,43(7):847-848.SCI
12. Ahn J*, Lee H, Lim JK, Pan CQ, Nguyen MH, Kim WR, Trinh HN, Tran TT, Chu D, Min A, Do ST, Woog J, Mannalithara A, Lok AS.Entecavir safety and effectiveness in a national cohort of chronic hepatitis B patients in the United States . Aliment Pharmacol Ther. . 2016,43(1):134-44.SCI
13. Pan CQ*, Han GR, Wang YM. Timing to initiated the therapy, cesearan section and breast feedings. N Engl J Med. 2016;375(15):1497-8..Timing to initiated the therapy, cesearan section and breast feedings. . N Engl J Med. . 2016,375(15):1497-8..SCI
14. Lok AS*, Pan CQ, Han SB,Trinh HN, Fessel WJ, Rodell T, Massetto B, Lin L, Gaggar A, Mani GS, McHutchison JG, Ferrari C, Lee H, Gordon SC, Gane EJ.Randomized phase II study of GS-4774 therapeutic vaccine in virally suppressed patients with chronic hepatitis B virus infection . J Hepatol. 2016,65(3):509-16.SCI
15. Buti M*, Gane E, Seto WK, Chan HL, Chuang W, Stepanova T, Hui A, Lim Y, Mehta R, Janssen H, Acharya SK, Flaherty JF, Massetto B, Cathcart A, Kim K, Gaggar A, Subramanian M, McHutchison JG, Pan C, Brunetto M, Izumi N, Marcellin P. Tenofovir alafenamide versus tenofovir disoproxil fumarate for the.Tenofovir alafenamide versus tenofovir disoproxil fumarate for the HBeAg-negative chronic hepatitis B: a randomized, double-blind, phase 3 non-inferiority trial. Lancet Gasteroenterol Hepatol. 2016,1(3):196-206..SCI
16. Ahn J*, Lee H, Lim JK, Lok AS , Nguyen MH, Pan CQ. Mannalithara A, Te H, Reddy KR,Trinh HN, Chu D, Tran TT, Lau D, Leduc T, Min A, Le LT, Bae H, Tran SV, Do ST, Hann HL, Wong C, Han S, Pillai A, Park J, Tong M, Scagliogne S, Wong J, Kim WR.Lower Observed Hepatocellular Carcinoma Incidence in Chronic Hepatitis B Patients Treated with Entecavir: Results of the ENUMERATE Study. Am J Gastroenterol . 2016,111:1297-304 .SCI
17. Yi W, Pan CQ,* Hao J, Hu Y, Liu M, Li L, Liang D.Risk of Vertical Transmission of Hepatitis B after Amniocentesis in HBs Antigen-Positive Mothers. Journal of Hepatol 2014; 60: 523-29.. Journal of Hepatol.. 2014,60:523-29.SCI
18. Zhang H, Pan CQ*, Pang Q, Tian R, Yan M, Liu X.Telbivudine or Lamivudine Use in Late Pregnancy Safely Reduce Perinatal Transmission of Hepatitis B Virus in Real-life Practice. Hepatol. 2014,60(2):468-76.SCI
主编或副主编的著作/译著
重要奖项
1. 美国医师学会 (American College of Physicians) 詹姆斯·布鲁斯的预防医学杰出贡献纪念奖 James D. Bruce Memorial Award for Distinguished Contributions in Preventive Medicine 荣誉 201804
2. 美国医师学会 (American College of Physicians) "医学大师"的称号 (Master of American College of Physicians) 荣誉 201704
3. 中华医学会感染病分会 突出贡献奖 荣誉 201606
4. 美国肝脏病学会 (AASLD) 资深会员 (FAASLD) 荣誉 201411